Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Lupus Erythematosus, Lupus Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01206569
What this trial is testing

Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis

Who this might be right for
Lupus Nephritis
Chinese University of Hong Kong 2
Not applicableStudy completedNCT04266860
What this trial is testing

Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients

Who this might be right for
Lupus NephritisLupus Erythematosus, Systemic
Qure Healthcare, LLC 166
Post-approval studies (Phase 4)Looking for participantsNCT07719140
What this trial is testing

Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)

Who this might be right for
Childhood-onset Systemic Lupus ErythematosusLupus Nephritis (LN)
Peking Union Medical College Hospital 198
Testing effectiveness (Phase 2)Study completedNCT01273389
What this trial is testing

An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC 25
Large-scale testing (Phase 3)Ended earlyNCT00430677
What this trial is testing

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 423
Not applicableStudy completedNCT00876616
What this trial is testing

Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Zhi-Hong Liu, M.D. 362
Testing effectiveness (Phase 2)Looking for participantsNCT06434363
What this trial is testing

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Who this might be right for
Autoimmune DisordersSystemic SclerosisSystemic Lupus Erythematosus+2 more
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Study completedNCT03610516
What this trial is testing

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 57
Early research (Phase 1)Looking for participantsNCT06308978
What this trial is testing

FT819 in B-cell Mediated Autoimmune Disease

Who this might be right for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)+2 more
Fate Therapeutics 244
Post-approval studies (Phase 4)Looking for participantsNCT07225387
What this trial is testing

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

Who this might be right for
Lupus Nephritis
NephroNet, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00050713
What this trial is testing

Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy

Who this might be right for
Membranous GlomerulonephritisLupus Membranous Nepropathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12
Post-approval studies (Phase 4)Looking for participantsNCT07760480
What this trial is testing

Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus (SLE)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 55
Not applicableLooking for participantsNCT02954939
What this trial is testing

The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
The University of Hong Kong 50
Testing effectiveness (Phase 2)Ended earlyNCT05938725
What this trial is testing

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - World Health Organization (WHO) Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 6
Very early researchLooking for participantsNCT07107659
What this trial is testing

Safety and Efficacy of ONT01 in Lupus

Who this might be right for
Lupus Nephritis (LN)Lupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IV+5 more
Hospital for Special Surgery, New York 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Large-scale testing (Phase 3)WithdrawnNCT05609812
What this trial is testing

Atacicept in Subjects With Active Lupus Nephritis (COMPASS)

Who this might be right for
Lupus Nephritis (LN)
Vera Therapeutics, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00447265
What this trial is testing

Etanercept for the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
National Institute of Allergy and Infectious Diseases (NIAID) 1
Very early researchNot Yet RecruitingNCT06681337
What this trial is testing

Universal CAR-T Cell Therapy for Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bioray Laboratories 10
Early research (Phase 1)Ended earlyNCT00479622
What this trial is testing

Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Wyeth is now a wholly owned subsidiary of Pfizer 20
Next Page